COLLECTION OF CONCORDANT MULTIMEDIA MEASUREMENTS TO EVALUATE PFAS HUMAN EXPOSURE PATHWAYS

0
1

Funding Opportunity ID:334615
Opportunity Number:EPA-G2021-ORD-D1
Opportunity Title:COLLECTION OF CONCORDANT MULTIMEDIA MEASUREMENTS TO EVALUATE PFAS HUMAN EXPOSURE PATHWAYS
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Grant
Category of Funding Activity:Environment
Category Explanation:
CFDA Number(s):66.511
Eligible Applicants:Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility:Please see Section III of the announcement for eligibility information.
Agency Code:EPA
Agency Name:Environmental Protection Agency
Posted Date:Jul 07, 2021
Close Date:Aug 23, 2021 Please refer to the announcement, including Section IV, for additional information on submission methods and due dates.
Last Updated Date:Jul 07, 2021
Award Ceiling:$250,000
Award Floor:$0
Estimated Total Program Funding:$500,000
Expected Number of Awards:2
Description:The U.S. Environmental Protection Agency’s (EPA) Center for Public Health and Environmental Assessment (CPHEA) in coordination with EPA’s Safe and Healthy Communities National Research Program, is requesting applications to supplement exposure measurements in cohorts where biomonitoring is being conducted for per- and poly-fluoroalkyl substances (PFAS). The data developed should enable or improve interpretation of biomonitoring data and inform understanding of the important sources and pathways related to personal exposures to PFAS chemicals. The overarching intention is to advance PFAS human exposure measurement methodologies and encourage common collection of concordant information that will increase impact of individual studies and enable understanding of the most important PFAS exposure pathways.
Version:1





Visit the Official Webpage For More Details on COLLECTION OF CONCORDANT MULTIMEDIA MEASUREMENTS TO EVALUATE PFAS HUMAN EXPOSURE PATHWAYS

LEAVE A REPLY

Please enter your comment!
Please enter your name here